Methods and compounds for treating retinol-related diseases

Details for Australian Patent Application No. 2008305303 (hide)

Owner Sirion Therapeutics, Inc.

Inventors Bui, Tam V.; Phan, Kim B.; Mata, Nathan L.; Haddach, Mustapha

Agent Spruson & Ferguson

Pub. Number AU-A-2008305303

PCT Pub. Number WO2009/042444

Priority 60/981,322 19.10.07 US; 60/975,765 27.09.07 US

Filing date 16 September 2008

Wipo publication date 2 April 2009

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/20 (2006.01)

A61K 31/203 (2006.01)

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/042444 Priority application(s): WO2009/042444

22 July 2010 Assignment before Grant

  Sirion Therapeutics, Inc. The application has been assigned to ReVision Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008305313-Automated sleep phenotyping

2008305294-Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus